drugset / Trial / NCT00570310

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

NCT00570310

Phase 1 Completed 104 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the best way to conduct clinical trials in patients with neuropathic pain (nerve pain). This study will see if generic pregabalin has any effect on neuropathic pain.

Timeline

Start
2007-12
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 600 mg Oral